Stryker Corporation
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Kevin A. Lobo
- Full Time Employees
- 53,000
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 1941 Stryker Way Portage MI United States of America 49002
- IPO Date
- Mar 17, 1980
- CIK
- 0000310764
- Website
- stryker.com
- Similar Companies
- Business
- Stryker Corporation (NYSE: SYK) develops, manufactures, and markets medical technologies, including orthopedic implants and instruments; surgical equipment and navigation systems; endoscopic and communications products; and patient handling and emergency medical equipment. The company offers its Mako robotic-arm assisted surgery platform for orthopedic procedures; Triathlon and Trident hip and knee systems; Gamma3 and T2 intramedullary nailing systems; and Ceros and Variax distal fixation systems, among other specialized devices for joint reconstruction, trauma and extremities, and spine care. Stryker provides interventional devices, including embolic products and guidewires, along with neurotechnology and spine products such as Vizor vision systems and SurgiCount safety sponges; it also delivers solutions for operating room integration and capital equipment. Founded in 1941 and headquartered in Kalamazoo, Michigan, the company operates globally across the Americas, Europe, Asia-Pacific, and other regions, serving hospitals, ambulatory surgery centers, and healthcare providers in the medtech industry. In recent developments, Stryker completed the acquisition of Artelon AB in September 2024, enhancing its sports medicine portfolio with advanced biomaterials for soft tissue regeneration. The company also acquired Wright Medical Group N.V. in 2022, bolstering its extremity reconstruction offerings, and continues to expand through strategic investments, including a new manufacturing facility in Ireland to support European growth. Additionally, Stryker launched the next-generation Mako Total Knee 2.0 application and advanced its Blue Seal bipolar sealer technology, reflecting ongoing innovation in robotics and surgical efficiency amid robust demand in orthopedics and neurotechnology segments.
Stryker: The Market Is Overreacting To One Disrupted Quarter
Beyond Automotive: Healthcare Automation Drives the Next Leg for Robotics ETFs
ICUI vs. SYK: Which Stock Should Value Investors Buy Now?
Stryker: Medtech On Sale, Benefiting From Industry Growth
Buy these quality, low-stress stocks for the summer, says Jefferies
Stryker: The Reshaped Product Portfolio Will Drive Growth
Stryker Vs. Intuitive Surgical: Stryker's Joint-Replacement Moat Over Intuitive's Premium Valuation
Stryker to announce second quarter 2026 financial results
Stryker Corp (SYK) Stock Down 4.7% -- Now Undervalued? GF Score: 92/100
Stryker (SYK) Moves 5.3% Higher: Will This Strength Last?
Stryker partners with professional golfer Shane Lowry to spotlight the caregiver journey in joint replacement
PAHC vs. SYK: Which Stock Is the Better Value Option?
Cramer Gives Vistra His Blessing, Backs Stryker, Steers Clear Of AI-Exposed FICO
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now
Stryker Launches TPX HD Power Tool for Complex Orthopedic Procedures
PAHC vs. SYK: Which Stock Should Value Investors Buy Now?
Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures
Is SYK Overvalued? DCF Says Worth $206
Stryker Launches Pangea Plating System in Europe for Fracture Fixation
Stryker Launches Pangea Plating System and Completes First Case in Europe